0001415889-24-019905.txt : 20240722
0001415889-24-019905.hdr.sgml : 20240722
20240722201850
ACCESSION NUMBER: 0001415889-24-019905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240718
FILED AS OF DATE: 20240722
DATE AS OF CHANGE: 20240722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aslan Fred
CENTRAL INDEX KEY: 0001909362
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42179
FILM NUMBER: 241132703
MAIL ADDRESS:
STREET 1: C/O ARTIVA BIOTHERAPEUTICS, INC.
STREET 2: 4747 EXECUTIVE DRIVE, SUITE 1150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Artiva Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001817241
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863614316
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5505 MOREHOUSE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 267-4467
MAIL ADDRESS:
STREET 1: 5505 MOREHOUSE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4-07232024_120741.xml
X0508
4
2024-07-18
0001817241
Artiva Biotherapeutics, Inc.
ARTV
0001909362
Aslan Fred
C/O ARTIVA BIOTHERAPEUTICS, INC.
5505 MOREHOUSE DRIVE, SUITE 100
SAN DIEGO
CA
92121
true
true
false
false
President and CEO
0
Common Stock
2024-07-22
4
A
0
228905
0
A
228905
D
Employee Stock Option (Right to Buy)
12
2024-07-18
4
A
0
343811
0
A
2034-07-17
Common Stock
343811
343811
D
Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Neha Krishnamohan, Attorney-in-Fact
2024-07-22